The human recombinant of PCSK9 and anti-PCSK9 were then used to evaluate the effect on thrombus formation, platelet aggregation, monocyte differentiation into foam cells, and monocyte migration, by which all led to the development of atherosclerosis progression-induced coronary artery disease [26]. Here, PCSK9 is linked to coronary artery disorder.